12 Sep 2023 | 03:00 PM GMT
Past Meeting

Digital Biomarkers in Neurology: Early Diagnosis & Disease Management

Participants:

Adam Cohen Chief Scientist, National Health Mission AreaJohns Hopkins Applied Physics Lab
Adam Cohen
Chief Scientist, National Health Mission AreaJohns Hopkins Applied Physics Lab
Brian Nahed Neurosurgeon and Program DirectorMassachusetts General Hospital
Brian Nahed
Neurosurgeon and Program DirectorMassachusetts General Hospital
Benjamin Alouf Chief Medical OfficerFloreoHealth Tech & Solutions
Health Tech & Solutions
Benjamin Alouf
Chief Medical OfficerFloreo
Cathy Zaremba Director, Product MarketingBrightInsightOther
Other
Cathy Zaremba
Director, Product MarketingBrightInsight
Cédric Odje Senior AssociateDebiopharm Innovation FundInvestor & Accelerators
Investor & Accelerators
Cédric Odje
Senior AssociateDebiopharm Innovation Fund
Danny Sands Chief Medical OfficerWKD.SMRTHealth Tech & Solutions
Health Tech & Solutions
Danny Sands
Chief Medical OfficerWKD.SMRT
Eva de Reuver Project coordinatorRoche
Eva de Reuver
Project coordinatorRoche
Gabriele Tundo PartnerPlexus VenturesProfessional Services
Professional Services
Gabriele Tundo
PartnerPlexus Ventures
Gaurav Shah Director - Business Development TransactionsBristol-Myers Squibb
Gaurav Shah
Director - Business Development TransactionsBristol-Myers Squibb
Jonathan Lake Senior Director, Digital Endpoint ConsultantActiGraphHealth Tech & Solutions
Health Tech & Solutions
Jonathan Lake
Senior Director, Digital Endpoint ConsultantActiGraph
Mansa Shroff Director of Business Dev & Chief of StaffWKD.SMRTOther
Other
Mansa Shroff
Director of Business Dev & Chief of StaffWKD.SMRT
Masayuki ‘Masa’ Asano Head of Partnership and Business DevelopmentMelon Inc.Other
Other
Masayuki ‘Masa’ Asano
Head of Partnership and Business DevelopmentMelon Inc.
Nigel Teh Assistant Vice President, Digital HealthClavystBio
Nigel Teh
Assistant Vice President, Digital HealthClavystBio
Patrick Leyseele Founder3.life
Patrick Leyseele
Founder3.life
Rafael Lira Carrillo Digital Innovation Hub ManagerMerz TherapeuticsLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Rafael Lira Carrillo
Digital Innovation Hub ManagerMerz Therapeutics
Sheena Dempsey Chief Solutions Officer Indivi
Sheena Dempsey
Chief Solutions Officer Indivi
Shi Kang Ng CEOEigenSensor
Shi Kang Ng
CEOEigenSensor
Ventsislav Dobrev Global Clinical Lead Digital BiomarkersRocheLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Ventsislav Dobrev
Global Clinical Lead Digital BiomarkersRoche
Wen Dombrowski MD MBA Chief Convergence OfficerCATALAIZEInvestor & Accelerators
Investor & Accelerators
Wen Dombrowski MD MBA
Chief Convergence OfficerCATALAIZE

About this Meeting

Neurological disorders, given their intricate nature and often elusive markers, pose a significant challenge to neurologists striving for early diagnosis and effective treatment. In the face of such complexity, emerging digital biomarkers, powered by advanced technology and comprehensive data analytics, offer great promise. They unlock a novel pathway to insights, facilitating not just early detection but also more adept management of neurological conditions. By harnessing data from devices and specific sensors, digital biomarkers are paving the way towards precision diagnostics and tailor-made therapeutic strategies.

If you are interested in the potential of digital biomarkers in neurology, and learning how to harness them effectively, join this roundtable discussion, anchored by Brian Nahed (Neurosurgeon and Program Director, Massachusetts General Hospital). The conversation will cover:

  • Harnessing Digital Biomarkers for Neurology: How can we best identify and use digital biomarkers for the early detection of neurological disorders? Which conditions hold the most potential, and what biomarkers are most suitable? 
  • Validation of Digital Biomarkers: Which digital biomarkers have already demonstrated their efficacy in neurology, and what regulatory guidelines and considerations are required?
  • Limitations of Current Digital Biomarkers: What practical applications and limitations exist for neurological biomarkers, and how to overcome these challenges?
  • Future of Digital Biomarkers in Neurology: What groundwork is required for these digital biomarkers to become standard tools for neurologists?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville, TN | Be First to Know | Sponsor
2027 | HLTH: Oct 17 – 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.